# Risk Assessment & Mitigation Strategy
## FDA 483 Form Analysis System

## 1. Data Quality & Accuracy Risks

### Risk 1.1: Incorrect Classification by AI Model
**Description:** OpenAI model may misclassify forms (OAI/VAI/NAI) leading to incorrect regulatory decisions.

**Impact:** HIGH - Regulatory compliance and patient safety implications

**Mitigation:**
- Implement human review workflow for all OAI classifications before finalization
- Use fine-tuned models trained on labeled historical data
- Add confidence scores to classifications
- Maintain audit trail of all AI decisions
- Implement validation checks against known patterns
- Regular model performance monitoring and retraining

**Controls:**
- Require supervisor approval for OAI classifications
- Compare AI classifications with historical patterns
- Track model accuracy metrics over time

---

### Risk 1.2: Missing or Incorrect Violation Codes
**Description:** AI may assign incorrect CFR codes or miss relevant violations.

**Impact:** HIGH - Enforcement actions based on incorrect codes

**Mitigation:**
- Cross-reference violations with FDA compliance program criteria
- Implement validation against known CFR code database
- Human expert review for all critical violations
- Use structured prompts with explicit CFR code examples
- Maintain updated reference database of valid codes

**Controls:**
- Automated validation of CFR codes against FDA database
- Expert review checklist for critical violations
- Flag unusual or unrecognized codes for review

---

### Risk 1.3: PDF Text Extraction Failures
**Description:** Poor quality PDFs or scanned documents may result in incomplete or corrupted text extraction.

**Impact:** MEDIUM - Missing observations leading to incomplete analysis

**Mitigation:**
- Implement OCR preprocessing for image-based PDFs
- Use multiple PDF extraction libraries (PyPDF2, pdfplumber, etc.)
- Add quality checks for extracted text
- Manual review flag for low-confidence extractions
- Fallback to manual entry for critical documents

**Controls:**
- Text quality scoring after extraction
- Automatic flagging of documents with <80% text extraction confidence
- Manual review queue for flagged documents

---

### Risk 1.4: Incorrect Firm Name or FEI Extraction
**Description:** Firm names or FEI numbers may be incorrectly extracted from PDFs.

**Impact:** MEDIUM - Data integrity and reporting issues

**Mitigation:**
- Cross-reference with Excel file data first (primary source)
- Use OpenAI for extraction with structured prompts
- Implement validation checks (FEI format, firm name length)
- Manual verification for critical firms
- Maintain master data file with verified firm information

**Controls:**
- Automated validation of FEI format (typically 10 digits)
- Flag mismatches between Excel and PDF data
- Manual verification workflow for high-priority firms

---

## 2. Technical & Infrastructure Risks

### Risk 2.1: OpenAI API Failures or Rate Limits
**Description:** API outages, rate limits, or service disruptions could halt processing.

**Impact:** HIGH - Processing delays, missed deadlines

**Mitigation:**
- Implement retry logic with exponential backoff
- Add request queuing system for batch processing
- Cache API responses where possible
- Monitor API usage and implement rate limiting
- Have fallback manual processing procedures
- Consider multiple API keys/accounts for redundancy

**Controls:**
- API health monitoring and alerting
- Automatic retry with exponential backoff (max 3 attempts)
- Queue management for batch jobs
- Daily API usage reports

---

### Risk 2.2: Data Loss or Corruption
**Description:** Results JSON files could be lost, corrupted, or overwritten.

**Impact:** HIGH - Loss of analysis results

**Mitigation:**
- Implement automated backups of results folder
- Version control for result files (append timestamps)
- Database storage option for critical data
- Regular backup to cloud storage
- Transaction logging for all operations

**Controls:**
- Daily automated backups
- Git version control for results
- Cloud backup (AWS S3, Google Cloud Storage)
- Recovery procedures documented

---

### Risk 2.3: Dashboard Performance Issues
**Description:** Large number of processed forms may slow down dashboard or cause crashes.

**Impact:** MEDIUM - User experience and productivity

**Mitigation:**
- Implement pagination for large datasets
- Add caching for frequently accessed data
- Optimize database queries (if moved to database)
- Lazy loading for details view
- Limit number of results displayed at once

**Controls:**
- Pagination (50 forms per page)
- Response time monitoring (<2 seconds)
- Load testing for 1000+ forms
- Caching layer for summary statistics

---

### Risk 2.4: Dependency Vulnerabilities
**Description:** Security vulnerabilities in third-party libraries could expose system.

**Impact:** MEDIUM - Security breaches

**Mitigation:**
- Regular dependency updates
- Security scanning (pip-audit, safety)
- Pin dependency versions
- Monitor security advisories
- Use virtual environments

**Controls:**
- Monthly dependency updates
- Automated security scanning in CI/CD
- Version pinning in requirements.txt
- Security audit log

---

## 3. Compliance & Regulatory Risks

### Risk 3.1: Non-Compliance with FDA Regulations
**Description:** System may not align with FDA compliance program requirements or procedures.

**Impact:** CRITICAL - Regulatory violations, legal issues

**Mitigation:**
- Regular review with FDA compliance experts
- Align with FDA Compliance Program Manual
- Document all classification logic and rationale
- Maintain audit trail of all decisions
- Regular updates when FDA guidance changes
- Legal/compliance review of system outputs

**Controls:**
- Quarterly compliance review
- Expert validation of classification criteria
- Documented decision trees
- Audit trail for all classifications
- Compliance officer sign-off on changes

---

### Risk 3.2: Inadequate Documentation
**Description:** Insufficient documentation of how classifications are determined.

**Impact:** MEDIUM - Regulatory scrutiny, inability to defend decisions

**Mitigation:**
- Comprehensive documentation of AI prompts
- Maintain version history of model prompts
- Document all fine-tuning decisions
- Clear explanation of classification rationale
- User guides and operational procedures

**Controls:**
- Version-controlled documentation
- Prompt templates stored in repository
- Change log for all modifications
- Regular documentation reviews

---

### Risk 3.3: Data Privacy & Security
**Description:** Sensitive FDA inspection data could be exposed or breached.

**Impact:** HIGH - Privacy violations, regulatory penalties

**Mitigation:**
- Encrypt data at rest and in transit
- Implement access controls and authentication
- Secure API key management (environment variables, secrets management)
- Regular security audits
- Compliance with data protection regulations
- Secure file storage and access logging

**Controls:**
- API keys in environment variables only
- HTTPS for all communications
- Access logging and monitoring
- Regular security assessments
- Data retention policies

---

## 4. Operational Risks

### Risk 4.1: Lack of Human Oversight
**Description:** Over-reliance on AI without adequate human review.

**Impact:** HIGH - Incorrect regulatory actions

**Mitigation:**
- Require human review for all OAI classifications
- Implement escalation procedures for critical violations
- Regular quality assurance audits
- Training programs for reviewers
- Clear approval workflows

**Controls:**
- Mandatory review for OAI and Critical violations
- Approval workflow in system
- Quality metrics tracking
- Monthly QA reviews

---

### Risk 4.2: Inconsistent Processing
**Description:** Different reviewers or processes may handle forms inconsistently.

**Impact:** MEDIUM - Quality and reliability issues

**Mitigation:**
- Standardized procedures and checklists
- Training programs for all users
- Quality assurance reviews
- Regular calibration sessions
- Clear escalation paths

**Controls:**
- Standard operating procedures (SOPs)
- Training documentation
- Quality metrics and benchmarks
- Regular team meetings for consistency

---

### Risk 4.3: Scalability Issues
**Description:** System may not handle large volumes of forms efficiently.

**Impact:** MEDIUM - Processing delays, system overload

**Mitigation:**
- Implement batch processing with queuing
- Add progress tracking and status updates
- Consider distributed processing
- Database optimization for large datasets
- Load testing and capacity planning

**Controls:**
- Batch processing with progress indicators
- Queue management system
- Performance monitoring
- Capacity planning reports

---

## 5. Model & AI-Specific Risks

### Risk 5.1: Model Drift
**Description:** AI model performance may degrade over time as data patterns change.

**Impact:** MEDIUM - Decreasing accuracy

**Mitigation:**
- Regular model performance monitoring
- Periodic retraining with new labeled data
- A/B testing of model versions
- Track accuracy metrics over time
- Update fine-tuning data regularly

**Controls:**
- Monthly accuracy reports
- Quarterly model retraining
- Version tracking and comparison
- Performance dashboards

---

### Risk 5.2: Fine-Tuning Data Quality
**Description:** Poor quality labeled data for fine-tuning leads to worse model performance.

**Impact:** MEDIUM - Model accuracy degradation

**Mitigation:**
- Expert review of all training labels
- Quality assurance on labeled data
- Validation set for testing
- Regular audits of labeled data
- Use validated historical classifications

**Controls:**
- Expert validation of training labels
- Quality metrics for labeled data
- Validation/testing procedures
- Regular data audits

---

### Risk 5.3: Prompt Injection or Manipulation
**Description:** Malicious or malformed input could manipulate AI outputs.

**Impact:** MEDIUM - Incorrect classifications

**Mitigation:**
- Input validation and sanitization
- Structured prompts with clear boundaries
- Output validation against expected formats
- Regular prompt testing and review
- Monitor for unusual patterns

**Controls:**
- Input sanitization functions
- Output format validation
- Anomaly detection
- Regular security reviews

---

## 6. Business Continuity Risks

### Risk 6.1: Key Person Dependency
**Description:** System knowledge concentrated in few individuals.

**Impact:** MEDIUM - Operational disruption if key people unavailable

**Mitigation:**
- Comprehensive documentation
- Cross-training of team members
- Knowledge sharing sessions
- Documented procedures
- Backup personnel assignments

**Controls:**
- Documentation repository
- Training programs
- Regular knowledge transfer
- Backup personnel list

---

### Risk 6.2: Vendor Lock-in (OpenAI)
**Description:** Over-dependence on OpenAI API could create issues if service changes.

**Impact:** MEDIUM - Operational disruption

**Mitigation:**
- Abstract API layer for easy switching
- Evaluate alternative AI providers
- Maintain ability to switch models
- Monitor OpenAI service changes
- Consider self-hosted alternatives

**Controls:**
- Abstraction layer in code
- Alternative provider evaluation
- Migration plan documented
- Regular vendor assessment

---

## Risk Priority Matrix

| Risk | Probability | Impact | Priority | Mitigation Status |
|------|------------|--------|---------|------------------|
| Incorrect Classification | Medium | High | **HIGH** | In Progress |
| API Failures | Low | High | **HIGH** | Planned |
| Data Loss | Low | High | **HIGH** | Planned |
| Compliance Issues | Low | Critical | **CRITICAL** | In Progress |
| Data Privacy | Medium | High | **HIGH** | Planned |
| PDF Extraction | Medium | Medium | **MEDIUM** | In Progress |
| Model Drift | Medium | Medium | **MEDIUM** | Planned |

## Recommended Next Steps

1. **Immediate (Week 1-2):**
   - Implement human review workflow for OAI classifications
   - Set up automated backups
   - Add input/output validation
   - Document all classification logic

2. **Short-term (Month 1):**
   - Implement API retry logic and monitoring
   - Add quality metrics tracking
   - Security audit and improvements
   - Create SOPs and training materials

3. **Medium-term (Months 2-3):**
   - Fine-tuning with labeled data
   - Performance optimization
   - Database migration for scalability
   - Compliance review with experts

4. **Long-term (Months 4-6):**
   - Model performance monitoring system
   - Advanced analytics and reporting
   - Integration with FDA systems (if applicable)
   - Continuous improvement program

## Monitoring & Review

- **Weekly:** API usage and error rates
- **Monthly:** Model accuracy metrics, quality assurance reviews
- **Quarterly:** Compliance review, security audit, risk assessment update
- **Annually:** Comprehensive system review and improvement plan

---

*Last Updated: November 2025*
*Review Date: Quarterly*

